Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Single-blind Parallel Controlled Clinical Trial of Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts

NCT07565350 is registered in ClinicalTrials.gov with First Hospital of China Medical University as lead sponsor.

NCT NCT07565350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07565350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Single-blind Parallel Controlled Clinical Trial of Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts
Lead sponsor
First Hospital of China Medical University
Phase
Not applicable
Overall status
Recruiting
Start date
October 1, 2025
Completion date
December 30, 2027
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

refactory warts